Recent Updates

Modified on: 
Dec 13, 2018

Organ Donation and Transplantation in Canada - System Progress Report 

Organs and Tissues
Modified on: 
Dec 12, 2018

Digital technology is transforming the way health care services are delivered in Canada. The Canadian Transplant Registry (CTR) is an example of an innovative technology that generates value in terms of quality, safety and efficiency through its capabilities for supporting all donors, candidate listing, offer management, allocation and pre and post-transplant data.  

The CTR is a national web-based computer program, used for linking the national potential recipient waitlist with actual organ donors. It features:

Organs and Tissues
Modified on: 
Nov 26, 2018

Coagulation factor concentrates are highly effective treatments for patients with hemostatic disorders caused by missing or defective clotting factors. Coagulation factor concentrates may be extracted from pooled donated plasma (plasma-derived) or manufactured using biotechnology (recombinant). In addition, several plasma-derived protein concentrates are available for the treatment of thrombotic disorders and hereditary angioedema.

Transfusion
Modified on: 
Nov 13, 2018

This chapter reviews the testing and treatments that are relevant for mothers and their fetuses/infants during pregnancy and postnatally to reduce the risks of hemolytic disease of the fetus and newborn (HDFN) and of immune thrombocytopenias.

Transfusion
Modified on: 
Nov 13, 2018

Platelets are the smallest of the blood cells, with a diameter of two to three microns and no nucleus. Their main function is to mediate primary hemostasis, though they are involved in a number of other processes including primary immunity, tumour progression and inflammation. 

Transfusion
Modified on: 
Nov 7, 2018

Organ and Tissue Donation and Transplantation (OTDT) Advisory Committees

A number of advisory committees and working groups work with Canadian Blood Services on issues and initiatives related to organ donation and transplantation activities. Their work includes providing expert advise and direction on national clinical policy and practice, operational requirements, standardization of procedures, and development of the Canadian Transplant Registry services. These groups also provide input to strategic direction and initiative development and prioritization.

Organs and Tissues
Modified on: 
Nov 5, 2018

NHLAAC provides a forum for improving and standardizing HLA laboratory practices in support of national registries and, in general, organ and tissue donation and transplantation (OTDT) in Canada

Organs and Tissues
Modified on: 
Nov 1, 2018

Molecular immunohematology refers to the detection of the molecular genetic basis of an antigen, rather than the antigen alone.  Use of molecular testing in clinical laboratories requires knowledge of the molecular basis of blood group antigens and the availability of suitable genotyping methods that can be used in our testing environment.

Transfusion
Modified on: 
Oct 25, 2018

We are pleased to provide on a regular basis a Surveillance Report describing infectious disease surveillance that our stakeholders can consult to make evidence-based decisions.

High quality and timely surveillance is key to the safety of the blood supply. This includes monitoring of transmissible disease markers that the blood is tested for (including bacteria), investigation of any reports of possible transfusion transmission, as well as a horizon scan for any new pathogens that may pose a risk now or in the future.

Transfusion

Pages